Search - tctmd.com

Displaying 181 - 190 of 190

Sort: Relevancy | Date

News Daily News

El Bloqueador de la Angiotensina Preserva la Función Endotelial Mejor que el Antagonista del Calcio

Jason Kahn

March 05, 2012

News Daily News

Stent Thrombosis, TLR Persist at Low Levels out to 5 Years with First-Gen DES

Jason Kahn

January 08, 2012

Presentation TCT 2012

5-year THUNDER Follow-Up: Patients with PAD Treated with Uncoated Versus Paccocath Paclitaxel Coated Balloons.

Presenter: Gunnar Tepe

January 03, 2012

News Daily News

First DES for Above-the-Knee Vascular Disease on the Horizon

L.A. McKeown

October 18, 2011

News Daily News

Drug-Eluting Balloons Show ‘Impressive’ Results in Below-the-Knee Lesions

Jason Kahn

September 08, 2011

News Industry News

NSVascular, Inc., a NeuroSigma Subsidiary, Signs an Exclusive License Covering UCLA's Thin-Film Nitinol (TFN) Stent Technology for Endovascular Applications

July 18, 2011

News Daily News

Zilver PTX: Novel DES for Femoropopliteal Disease Encouraging at 2 Years

January 17, 2011

News Daily News

CILON-T Published: Cilostazol Reduces Platelet Reactivity, Not Events

January 09, 2011

News Daily News

Benefit of Sirolimus Stents Sharply Attenuated in Dialysis Patients

January 04, 2011

News Industry News

Advertisement

El Bloqueador de la Angiotensina Preserva la Función Endotelial Mejor que el Antagonista del Calcio

Stent Thrombosis, TLR Persist at Low Levels out to 5 Years with First-Gen DES

5-year THUNDER Follow-Up: Patients with PAD Treated with Uncoated Versus Paccocath Paclitaxel Coated Balloons.

First DES for Above-the-Knee Vascular Disease on the Horizon

Drug-Eluting Balloons Show ‘Impressive’ Results in Below-the-Knee Lesions

NSVascular, Inc., a NeuroSigma Subsidiary, Signs an Exclusive License Covering UCLA's Thin-Film Nitinol (TFN) Stent Technology for Endovascular Applications

Zilver PTX: Novel DES for Femoropopliteal Disease Encouraging at 2 Years

CILON-T Published: Cilostazol Reduces Platelet Reactivity, Not Events

Benefit of Sirolimus Stents Sharply Attenuated in Dialysis Patients

Medtronic Drug-Coated Balloon (DCB) Demonstrates Consistent Results in Two New Analyses of Complex PAD Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content